ArticleCancer immunology, immunotherapy : CII2023

Considerations regarding the tumor-suppressor role of naringenin as a novel agent for the treatment of oral squamous cell carcinoma.

Chen-Xi Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.